> There is no evidence that ADE facilitates the spread of SARS-CoV in infected hosts. In fact, infection of macrophages through ADE does not result in productive viral replication and shedding
"suboptimal antibody responses" are indeed...suboptimal...but the paper here is not showing that. As the OP noted, the concerning result is limited to a few examples of monoclonal antibodies. The human immune response is much more complicated.
As for increased infectivity, that is at the core of what is understood to occur in ADE. And in general, cases where the Fc mediated response is utilized to gain entry to immune cells. I believe Dengue is the typical example spoken to, but this pattern has been observed in Zika, HIV, RSV off the top of my head.
Lots of editing! Also, did not state that ADE occurs for SARS-CoV2. The fact that studies indicate it does not replicate or shed after phagocytosis is a positive signal.
>> In many cases, binding antibodies increase cell infectivity.
^ This is what you wrote. It is unsupported. ADE is rare, and it has not been observed with this virus.
Also, what I wrote is not speculation:
The potential danger of suboptimal antibody responses in COVID-19 (https://www.nature.com/articles/s41577-020-0321-6) (Overview)
COVID-19-neutralizing antibodies predict disease severity and survival (https://www.sciencedirect.com/science/article/pii/S009286742...)